Xcell Therapeutics focuses on advancing regenerative medicine through its innovative CellCor™ technology platform, which includes a range of serum-free, chemically defined media designed to optimize cell culture environments. This platform is particularly notable for its ability to replace animal-derived components with small molecules, ensuring that the media is truly animal-origin free. The company has developed specialized media for various cell types, including dermal papilla cells, keratinocytes, and immune cells like NK and T cells. This commitment to creating high-quality, defined media is supported by a robust database of over 1,000 raw materials, which enhances the efficiency and yield of cell cultures.

In addition to media development, Xcell Therapeutics is pioneering the clonal selection of mesenchymal stem cells (MSCs) to produce high-purity cell lines with specific characteristics. Their automated mass cell culture platform aims to streamline the production of cells and exosomes, ensuring safety and economic feasibility for next-generation cell therapies. The company is also focused on developing a mass exosome cultivation platform, which will facilitate the profiling and characterization of exosomes derived from MSCs. Through these synergistic technologies, Xcell Therapeutics is positioned to contribute significantly to the global regenerative medicine market while adhering to eco-friendly practices that reduce greenhouse gas emissions associated with traditional serum production.

South Korea

At Xcell Therapeutics, we believe that scientists and researchers should have  the opportunity to develop groundbreaking treatments to cure disease, ensure good health, and limit animal suffering in research. That's why we have develop and produce serum-free, chemically defined media that provides for better research results and greater consistency in  manufacturing. Our media is carefully designed and manufactured with precision to help our customers in bioengineering and life sciences achieve a better future for humanity.

Dongwon Bldg. 6F, 333, Yeongdong-daero, Gangnam-gu, Seoul, Republic of Korea, Dongwon Bldg, Gangnam-gu, Seoul, 06188, KR

Xcell Therapeutics

Company Details